                               SEQUENCE LISTING	

<110> MOYO, VICTOR
      PEARLBERG, JOSEPH
      TABAH-FISCH, ISABELLE
       
<120> TREATMENT OF ADVANCED SOLID TUMORS USING COMBINATION OF ANTI-ERBB3 IMMUNOTHERAPY AND SELECTED CHEMOTHERAPY

<130> MMJ-040PC

<150> 61/535,303
<151> 2011-09-15

<150> 61/616,902
<151> 2012-03-28

<150> 61/522,063
<151> 2011-08-10

<150> 61/530,935
<151> 2011-09-02

<150> 61/638,611
<151> 2012-04-26

<160> 13   

<170> PatentIn version 3.5

<210> 1
<211> 357
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 1
gaggtgcagc tgctggagag cggcggaggg ctggtccagc caggcggcag cctgaggctg       60

tcctgcgccg ccagcggctt caccttcagc cactacgtga tggcctgggt gcggcaggcc      120

ccaggcaagg gcctggaatg ggtgtccagc atcagcagca gcggcggctg gaccctgtac      180

gccgacagcg tgaagggcag gttcaccatc agcagggaca acagcaagaa caccctgtac      240

ctgcagatga acagcctgag ggccgaggac accgccgtgt actactgcac caggggcctg      300

aagatggcca ccatcttcga ctactggggc cagggcaccc tggtgaccgt gagcagc         357



<210> 2
<211> 119
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 2
Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser His Tyr 
            20                  25                  30          


Val Met Ala Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ser Ile Ser Ser Ser Gly Gly Trp Thr Leu Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Thr Arg Gly Leu Lys Met Ala Thr Ile Phe Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210> 3
<211> 333
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 3
cagtccgccc tgacccagcc cgccagcgtg agcggcagcc caggccagag catcaccatc       60

agctgcaccg gcaccagcag cgacgtgggc agctacaacg tggtgtcctg gtatcagcag      120

caccccggca aggcccccaa gctgatcatc tacgaggtgt cccagaggcc cagcggcgtg      180

agcaacaggt tcagcggcag caagagcggc aacaccgcca gcctgaccat cagcggcctg      240

cagaccgagg acgaggccga ctactactgc tgcagctacg ccggcagcag catcttcgtg      300

atcttcggcg gagggaccaa ggtgaccgtc cta                                   333


<210> 4
<211> 111
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 4
Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ser Tyr 
            20                  25                  30          


Asn Val Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Ile Ile Tyr Glu Val Ser Gln Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Thr Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly Ser 
                85                  90                  95      


Ser Ile Phe Val Ile Phe Gly Gly Gly Thr Lys Val Thr Val Leu 
            100                 105                 110     


<210> 5
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
His Tyr Val Met Ala 
1               5   


<210> 6
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Ser Ile Ser Ser Ser Gly Gly Trp Thr Leu Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210> 7
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Gly Leu Lys Met Ala Thr Ile Phe Asp Tyr 
1               5                   10  


<210> 8
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 8
Thr Gly Thr Ser Ser Asp Val Gly Ser Tyr Asn Val Val Ser 
1               5                   10                  


<210> 9
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 9
Glu Val Ser Gln Arg Pro Ser 
1               5           


<210> 10
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 10
Cys Ser Tyr Ala Gly Ser Ser Ile Phe Val Ile 
1               5                   10      


<210> 11
<211> 1321
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 11
Ser Glu Val Gly Asn Ser Gln Ala Val Cys Pro Gly Thr Leu Asn Gly 
1               5                   10                  15      


Leu Ser Val Thr Gly Asp Ala Glu Asn Gln Tyr Gln Thr Leu Tyr Lys 
            20                  25                  30          


Leu Tyr Glu Arg Cys Glu Val Val Met Gly Asn Leu Glu Ile Val Leu 
        35                  40                  45              


Thr Gly His Asn Ala Asp Leu Ser Phe Leu Gln Trp Ile Arg Glu Val 
    50                  55                  60                  


Thr Gly Tyr Val Leu Val Ala Met Asn Glu Phe Ser Thr Leu Pro Leu 
65                  70                  75                  80  


Pro Asn Leu Arg Val Val Arg Gly Thr Gln Val Tyr Asp Gly Lys Phe 
                85                  90                  95      


Ala Ile Phe Val Met Leu Asn Tyr Asn Thr Asn Ser Ser His Ala Leu 
            100                 105                 110         


Arg Gln Leu Arg Leu Thr Gln Leu Thr Glu Ile Leu Ser Gly Gly Val 
        115                 120                 125             


Tyr Ile Glu Lys Asn Asp Lys Leu Cys His Met Asp Thr Ile Asp Trp 
    130                 135                 140                 


Arg Asp Ile Val Arg Asp Arg Asp Ala Glu Ile Val Val Lys Asp Asn 
145                 150                 155                 160 


Gly Arg Ser Cys Pro Pro Cys His Glu Val Cys Lys Gly Arg Cys Trp 
                165                 170                 175     


Gly Pro Gly Ser Glu Asp Cys Gln Thr Leu Thr Lys Thr Ile Cys Ala 
            180                 185                 190         


Pro Gln Cys Asn Gly His Cys Phe Gly Pro Asn Pro Asn Gln Cys Cys 
        195                 200                 205             


His Asp Glu Cys Ala Gly Gly Cys Ser Gly Pro Gln Asp Thr Asp Cys 
    210                 215                 220                 


Phe Ala Cys Arg His Phe Asn Asp Ser Gly Ala Cys Val Pro Arg Cys 
225                 230                 235                 240 


Pro Gln Pro Leu Val Tyr Asn Lys Leu Thr Phe Gln Leu Glu Pro Asn 
                245                 250                 255     


Pro His Thr Lys Tyr Gln Tyr Gly Gly Val Cys Val Ala Ser Cys Pro 
            260                 265                 270         


His Asn Phe Val Val Asp Gln Thr Ser Cys Val Arg Ala Cys Pro Pro 
        275                 280                 285             


Asp Lys Met Glu Val Asp Lys Asn Gly Leu Lys Met Cys Glu Pro Cys 
    290                 295                 300                 


Gly Gly Leu Cys Pro Lys Ala Cys Glu Gly Thr Gly Ser Gly Ser Arg 
305                 310                 315                 320 


Phe Gln Thr Val Asp Ser Ser Asn Ile Asp Gly Phe Val Asn Cys Thr 
                325                 330                 335     


Lys Ile Leu Gly Asn Leu Asp Phe Leu Ile Thr Gln Gly Asp Pro Trp 
            340                 345                 350         


His Lys Ile Pro Ala Leu Asp Pro Glu Lys Leu Asn Val Phe Arg Thr 
        355                 360                 365             


Val Arg Glu Ile Thr Gly Tyr Leu Asn Ile Gln Ser Trp Pro Pro His 
    370                 375                 380                 


Met His Asn Phe Ser Val Phe Ser Asn Leu Thr Thr Ile Gly Gly Arg 
385                 390                 395                 400 


Ser Leu Tyr Asn Arg Gly Phe Ser Leu Leu Ile Met Lys Asn Leu Asn 
                405                 410                 415     


Val Thr Ser Leu Gly Phe Arg Ser Leu Lys Glu Ile Ser Ala Gly Arg 
            420                 425                 430         


Ile Tyr Ile Ser Ala Asn Arg Gln Leu Cys Tyr His His Ser Leu Asn 
        435                 440                 445             


Trp Thr Lys Val Leu Arg Gly Pro Thr Glu Glu Arg Leu Asp Ile Lys 
    450                 455                 460                 


His Asn Arg Pro Arg Arg Asp Cys Val Ala Glu Gly Lys Val Cys Asp 
465                 470                 475                 480 


Pro Leu Cys Ser Ser Gly Gly Cys Trp Gly Pro Gly Pro Gly Gln Cys 
                485                 490                 495     


Leu Ser Cys Arg Asn Tyr Ser Arg Gly Gly Val Cys Val Thr His Cys 
            500                 505                 510         


Asn Phe Leu Asn Gly Glu Pro Arg Glu Phe Ala His Glu Ala Glu Cys 
        515                 520                 525             


Phe Ser Cys His Pro Glu Cys Gln Pro Met Glu Gly Thr Ala Thr Cys 
    530                 535                 540                 


Asn Gly Ser Gly Ser Asp Thr Cys Ala Gln Cys Ala His Phe Arg Asp 
545                 550                 555                 560 


Gly Pro His Cys Val Ser Ser Cys Pro His Gly Val Leu Gly Ala Lys 
                565                 570                 575     


Gly Pro Ile Tyr Lys Tyr Pro Asp Val Gln Asn Glu Cys Arg Pro Cys 
            580                 585                 590         


His Glu Asn Cys Thr Gln Gly Cys Lys Gly Pro Glu Leu Gln Asp Cys 
        595                 600                 605             


Leu Gly Gln Thr Leu Val Leu Ile Gly Lys Thr His Leu Thr Met Ala 
    610                 615                 620                 


Leu Thr Val Ile Ala Gly Leu Val Val Ile Phe Met Met Leu Gly Gly 
625                 630                 635                 640 


Thr Phe Leu Tyr Trp Arg Gly Arg Arg Ile Gln Asn Lys Arg Ala Met 
                645                 650                 655     


Arg Arg Tyr Leu Glu Arg Gly Glu Ser Ile Glu Pro Leu Asp Pro Ser 
            660                 665                 670         


Glu Lys Ala Asn Lys Val Leu Ala Arg Ile Phe Lys Glu Thr Glu Leu 
        675                 680                 685             


Arg Ser Leu Lys Val Leu Gly Ser Gly Val Phe Gly Thr Val His Lys 
    690                 695                 700                 


Gly Val Trp Ile Pro Glu Gly Glu Ser Ile Lys Ile Pro Val Cys Ile 
705                 710                 715                 720 


Lys Val Ile Glu Asp Lys Ser Gly Arg Gln Ser Phe Gln Ala Val Thr 
                725                 730                 735     


Asp His Met Leu Ala Ile Gly Ser Leu Asp His Ala His Ile Val Arg 
            740                 745                 750         


Leu Leu Gly Leu Cys Pro Gly Ser Ser Leu Gln Leu Val Thr Gln Tyr 
        755                 760                 765             


Leu Pro Leu Gly Ser Leu Leu Asp His Val Arg Gln His Arg Gly Ala 
    770                 775                 780                 


Leu Gly Pro Gln Leu Leu Leu Asn Trp Gly Val Gln Ile Ala Lys Gly 
785                 790                 795                 800 


Met Tyr Tyr Leu Glu Glu His Gly Met Val His Arg Asn Leu Ala Ala 
                805                 810                 815     


Arg Asn Val Leu Leu Lys Ser Pro Ser Gln Val Gln Val Ala Asp Phe 
            820                 825                 830         


Gly Val Ala Asp Leu Leu Pro Pro Asp Asp Lys Gln Leu Leu Tyr Ser 
        835                 840                 845             


Glu Ala Lys Thr Pro Ile Lys Trp Met Ala Leu Glu Ser Ile His Phe 
    850                 855                 860                 


Gly Lys Tyr Thr His Gln Ser Asp Val Trp Ser Tyr Gly Val Thr Val 
865                 870                 875                 880 


Trp Glu Leu Met Thr Phe Gly Ala Glu Pro Tyr Ala Gly Leu Arg Leu 
                885                 890                 895     


Ala Glu Val Pro Asp Leu Leu Glu Lys Gly Glu Arg Leu Ala Gln Pro 
            900                 905                 910         


Gln Ile Cys Thr Ile Asp Val Tyr Met Val Met Val Lys Cys Trp Met 
        915                 920                 925             


Ile Asp Glu Asn Ile Arg Pro Thr Phe Lys Glu Leu Ala Asn Glu Phe 
    930                 935                 940                 


Thr Arg Met Ala Arg Asp Pro Pro Arg Tyr Leu Val Ile Lys Arg Glu 
945                 950                 955                 960 


Ser Gly Pro Gly Ile Ala Pro Gly Pro Glu Pro His Gly Leu Thr Asn 
                965                 970                 975     


Lys Lys Leu Glu Glu Val Glu Leu Glu Pro Glu Leu Asp Leu Asp Leu 
            980                 985                 990         


Asp Leu Glu Ala Glu Glu Asp Asn  Leu Ala Thr Thr Thr  Leu Gly Ser 
        995                 1000                 1005             


Ala Leu  Ser Leu Pro Val Gly  Thr Leu Asn Arg Pro  Arg Gly Ser 
    1010                 1015                 1020             


Gln Ser  Leu Leu Ser Pro Ser  Ser Gly Tyr Met Pro  Met Asn Gln 
    1025                 1030                 1035             


Gly Asn  Leu Gly Glu Ser Cys  Gln Glu Ser Ala Val  Ser Gly Ser 
    1040                 1045                 1050             


Ser Glu  Arg Cys Pro Arg Pro  Val Ser Leu His Pro  Met Pro Arg 
    1055                 1060                 1065             


Gly Cys  Leu Ala Ser Glu Ser  Ser Glu Gly His Val  Thr Gly Ser 
    1070                 1075                 1080             


Glu Ala  Glu Leu Gln Glu Lys  Val Ser Met Cys Arg  Ser Arg Ser 
    1085                 1090                 1095             


Arg Ser  Arg Ser Pro Arg Pro  Arg Gly Asp Ser Ala  Tyr His Ser 
    1100                 1105                 1110             


Gln Arg  His Ser Leu Leu Thr  Pro Val Thr Pro Leu  Ser Pro Pro 
    1115                 1120                 1125             


Gly Leu  Glu Glu Glu Asp Val  Asn Gly Tyr Val Met  Pro Asp Thr 
    1130                 1135                 1140             


His Leu  Lys Gly Thr Pro Ser  Ser Arg Glu Gly Thr  Leu Ser Ser 
    1145                 1150                 1155             


Val Gly  Leu Ser Ser Val Leu  Gly Thr Glu Glu Glu  Asp Glu Asp 
    1160                 1165                 1170             


Glu Glu  Tyr Glu Tyr Met Asn  Arg Arg Arg Arg His  Ser Pro Pro 
    1175                 1180                 1185             


His Pro  Pro Arg Pro Ser Ser  Leu Glu Glu Leu Gly  Tyr Glu Tyr 
    1190                 1195                 1200             


Met Asp  Val Gly Ser Asp Leu  Ser Ala Ser Leu Gly  Ser Thr Gln 
    1205                 1210                 1215             


Ser Cys  Pro Leu His Pro Val  Pro Ile Met Pro Thr  Ala Gly Thr 
    1220                 1225                 1230             


Thr Pro  Asp Glu Asp Tyr Glu  Tyr Met Asn Arg Gln  Arg Asp Gly 
    1235                 1240                 1245             


Gly Gly  Pro Gly Gly Asp Tyr  Ala Ala Met Gly Ala  Cys Pro Ala 
    1250                 1255                 1260             


Ser Glu  Gln Gly Tyr Glu Glu  Met Arg Ala Phe Gln  Gly Pro Gly 
    1265                 1270                 1275             


His Gln  Ala Pro His Val His  Tyr Ala Arg Leu Lys  Thr Leu Arg 
    1280                 1285                 1290             


Ser Leu  Glu Ala Thr Asp Ser  Ala Phe Asp Asn Pro  Asp Tyr Trp 
    1295                 1300                 1305             


His Ser  Arg Leu Phe Pro Lys  Ala Asn Ala Gln Arg  Thr 
    1310                 1315                 1320     



<210> 12
<211> 445
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 12
1 	EVQLLESGGG LVQPGGSLRL SCAASGFTFS HYVMAWVRQA PGKGLEWVSS
51 	ISSSGGWTLY ADSVKGRFTI SRDNSKNTLY LQMNSLRAED TAVYYCTRGL
101 	KMATIFDYWG QGTLVTVSSA STKGPSVFPL APCSRSTSES TAALGCLVKD
151 	YFPEPVTVSW NSGALTSGVH TFPAVLQSSG LYSLSSVVTV PSSNFGTQTY
201 	TCNVDHKPSN TKVDKTVERK CCVECPPCPA PPVAGPSVFL FPPKPKDTLM
251 	ISRTPEVTCV VVDVSHEDPE VQFNWYVDGV EVHNAKTKPR EEQFNSTFRV
301 	VSVLTVVHQD WLNGKEYKCK VSNKGLPAPI EKTISKTKGQ PREPQVYTLP
351 	PSREEMTKNQ VSLTCLVKGF YPSDIAVEWE SNGQPENNYK TTPPMLDSDG
401 	SFFLYSKLTV DKSRWQQGNV FSCSVMHEAL HNHYTQKSLS LSPGK


<210> 13
<211> 217
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 13
1 	QSALTQPASV SGSPGQSITI SCTGTSSDVG SYNVVSWYQQ HPGKAPKLII
51 	YEVSQRPSGV SNRFSGSKSG NTASLTISGL QTEDEADYYC CSYAGSSIFV
101 	IFGGGTKVTV LGQPKAAPSV TLFPPSSEEL QANKATLVCL VSDFYPGAVT
151 	VAWKADGSPV KVGVETTKPS KQSNNKYAAS SYLSLTPEQW KSHRSYSCRV
201 	THEGSTVEKT VAPAECS






